Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 31, 2022Current Pharmaceutical Design

Identification of PSMB9 and CXCL13 as Immune-related Diagnostic Markers forRheumatoid Arthritis by Machine Learning

View Full Paper
Ask AI
Bookmark
Share

Authors

ZLZhuo LiYCYue ChenZMZulipikaer Maimaiti

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2022) studied this question.

synapsesocial.com/papers/69da97580f32475823a3d6b2https://doi.org/10.2174/1381612828666220831085608
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Transcriptomic and epigenomic analyses uncovered Lrrc15 as a contributing factor to cartilage damage in osteoarthritis2021 · 12 citations
  2. 2The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus2015 · 34 citations
  3. 3Thymic Stromal Lymphopoietin, a Novel Proinflammatory Mediator in Rheumatoid Arthritis That Potently Activates CD1c+ Myeloid Dendritic Cells to Attract and Stimulate T Cells2014 · 57 citations
  4. 4The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis2006 · 528 citations